FDA Drug Safety Communication: FDA advises of rare cases of underactive thyroid in infants given iodine-containing contrast agents for medical imaging

[11-17-2015] The U.S. Food and Drug Administration (FDA) is advising that rare cases of underactive thyroid have been reported in infants following the use of contrast media containing iodine, also called “contrast dye,” for X-rays and other medical imaging procedures.

Source: FDA Center for Drug Evaluation and Research - What's New - March 25, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news